Scientists have been encouraging older people to exercise in order to stay healthy, but according to a recent study, air pollution makes this rather pointless. What’s more, another study found that a dirty atmosphere has severe health impacts on unborn babies, which could lead to lifelong complications that could affect their development.
In the first study, researchers looked at the health effects of exercise for people aged 60 years old and up in an urban setting with lots of air pollution. The scientists then compared these participants to subjects who live in areas with cleaner air. As anyone could have predicted, those who exercise in areas with heavy smog don’t get as many health benefits, particularly with regards to their respiratory and cardiovascular systems.
“Short-term exposure to traffic pollution prevents the beneficial cardiopulmonary effects of walking in people with COPD [chronic obstructive pulmonary disease], ischaemic heart disease, and those free from chronic cardiopulmonary diseases,” the study reads.
In contrast, those who exercised in regions where air pollution was minimal did experience more health benefits. What really makes these findings serious is that it leaves residents of places with heavy smog with few choices as to how they can improve their health, short of actually moving.
With regards to the second study involving the adverse effects of air pollution on unborn children, the researchers found that it could lead to lower weights when the babies are born. This could then have massive consequences to the development of the children, which would then cause recurring or permanent impairments to their bodies.
Making the situation worse is that many pregnant women really don’t have much of a choice in terms of how they can avoid chronic exposure to pollution in the atmosphere. This means that it’s up to government regulators to look after the health of future generations.


U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Neuralink Expands Brain Implant Trials with 12 Global Patients
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 



